Ivanova et al. (2022) suggested that high levels of sclerostin, associated with lower bone mineral density (BMD) in patients with Gaucher disease, involve the Wnt/β-catenin pathway in bone pathology [23]. The gene discussed is SOST; the disease is Gaucher disease.